2004
DOI: 10.1111/j.1365-2788.2003.00554.x
|View full text |Cite
|
Sign up to set email alerts
|

Urinary compounds in autism

Abstract: The results would support the idea of a biological marker in prepubertal children and that it may be absent in, or obscured by the presence of severe LD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…Abnormal levels of IAcrGly have been reported in a number of conditions including the photodermatitic condition, polymorphous light eruption (Marklova et al, 1975) and Hartnup disease (Jepson, 1965). Based on differing symptom phenotypes, various levels of IAcrGly have been detected in the urine of people with pervasive developmental disorder (PDD) (Shattock and Whiteley, 2002;Alcorn et al, 2004), although the precise relationship to the syndrome is unknown. PDD includes a number of heterogeneous conditions including autism (Kanner, 1943) and Asperger syndrome (Asperger, 1944).…”
Section: Introductionmentioning
confidence: 99%
“…Abnormal levels of IAcrGly have been reported in a number of conditions including the photodermatitic condition, polymorphous light eruption (Marklova et al, 1975) and Hartnup disease (Jepson, 1965). Based on differing symptom phenotypes, various levels of IAcrGly have been detected in the urine of people with pervasive developmental disorder (PDD) (Shattock and Whiteley, 2002;Alcorn et al, 2004), although the precise relationship to the syndrome is unknown. PDD includes a number of heterogeneous conditions including autism (Kanner, 1943) and Asperger syndrome (Asperger, 1944).…”
Section: Introductionmentioning
confidence: 99%
“…Soluble CD26 in the plasma was found to be only insignificantly different in one small study (Hunter, O'Hare, Herron, Fisher, & Jones, 2003), indicating that this deficiency may be primarily localised in the intestine. There is mounting evidence of the presence of caseomorphin and gluteomorphin, casein and gluten metabolites and other opioid peptides in the urine, (Alcorn et al, 2004;Cade, 2000;Reichelt, 1990) which together with the response of some children to GFCF diets, (Knivsberg, Reichelt, Høien, & Nødland, 2002) as is the case with Child A, further supports this possible connection.…”
Section: Discussionmentioning
confidence: 97%
“…Therefore, our journey delving into the etiology of ASD initially involved an exploration into the idea of increased intestinal permeability [19], also referred to as the "leaky gut syndrome." This syndrome describes the passage of potentially bioactive peptides, created from the incomplete breakdown of the proteins through the intestinal membrane, into the blood stream and ultimately into the brain through the blood-brain barrier (BBB) [20][21][22][23]. The combined work of Panksepp [15], Shattock [17,18,24,25], Waring [26], Gardner [27], and Reichelt [28] caused us to pursue this area of research.…”
Section: The Opioid Excess Theory Of Autismmentioning
confidence: 99%